Hamilton Launches GlucoSense for Real-Time Glucose Monitoring
Hamilton, known for its innovative solutions in bioprocess analytics, has recently unveiled GlucoSense, a pioneering glucose sensor designed specifically for mammalian cell culture. This advanced sensor promises to deliver continuous, real-time glucose measurements right within cell culture bioreactors, changing the way bioprocessing teams monitor this critical parameter.
Advancements in Bioprocess Analytics
The introduction of GlucoSense marks a significant leap in process technology. Bioprocessing teams often face the challenge of obtaining precise glucose readings due to reliance on offline measurements that occur only a few times daily. This sporadic monitoring can lead to unnoticed fluctuations, compromising the integrity of the cell culture processes. GlucoSense aims to eliminate this blind spot by offering an intuitive solution that works seamlessly within existing workflows.
Functional Design of GlucoSense
Initially, GlucoSense will cater to wetted autoclave workflows, supporting the glass and benchtop bioreactors prevalent in research and development stages. Hamilton is already working on a future version that will be compatible with steel bioreactors, further broadening the applicability of this innovative technology for clinical and commercial manufacturing needs.
End-User Convenience and Reliability
This sensor’s compact design features a PG13.5-compatible optical probe tailored for cell culture environments, ensuring it withstands rigorous conditions without compromising data quality. Unlike previous systems reliant on fragile fiber optics, GlucoSense eliminates this issue, providing a robust sterilization process suited for repeated autoclave cycles. With mid-infrared ATR spectroscopy, it captures glucose-specific absorption features, simplifying the measurement process.
Collaboration with Research Institutions
To validate GlucoSense’s performance, Hamilton collaborated with the University of Applied Sciences and Arts Northwestern Switzerland (FHNW). The results from this collaboration have been promising. During experiments using fed-batch processes, GlucoSense maintained stable, drift-free glucose profiles for approximately 130 hours, demonstrating accuracy comparable to offline measurements.
Testing Over Extended Cultivation Periods
In rigorous high-density perfusion runs, where cell concentrations reached up to 50 million cells/mL, GlucoSense remained reliable, providing consistent glucose values that aligned well with biomass growth trends. This ability to monitor glucose continuously represents a transformative step in enhancing process robustness and product quality.
Future Perspectives on Bioprocessing
As the landscape of bioprocessing evolves, the demand for smarter, more agile solutions grows. With GlucoSense, Hamilton is at the forefront of enabling organizations to embrace innovations like automation and AI-driven optimization. The anticipated development of a sterilization-in-place (SIP) compatible version promises to extend monitoring capabilities across various stages, from early R&D to large-scale Good Manufacturing Practices (GMP) operations.
The Role of GlucoSense in the Future
In a world where biologics manufacturing is increasingly data-driven, continuous nutrient monitoring becomes crucial. The introduction of GlucoSense empowers manufacturers by offering vital insights into nutrient dynamics, effectively aiding in the transition towards intensified and continuous processing methodologies. With its sturdy design and easy integration, GlucoSense sets a new benchmark for real-time monitoring in cell culture bioprocesses.
About Hamilton
Hamilton is a renowned global manufacturer specializing in automated liquid handling workstations, laboratory automation technologies, and process analytical sensors tailored for the scientific community. Known for advancing various industries, including life sciences and biotechnology, Hamilton products emphasize reliability and performance, built through rigorous quality assurance processes. With manufacturing facilities located in multiple countries, Hamilton stands committed to supporting scientific advancements worldwide.
Frequently Asked Questions
What is GlucoSense?
GlucoSense is a real-time glucose sensor developed by Hamilton for monitoring glucose levels directly within mammalian cell culture bioreactors.
How does GlucoSense improve bioprocessing?
It eliminates the need for offline measurements, providing continuous data on glucose levels, which enhances process monitoring and product quality.
What technologies are used in GlucoSense?
The sensor utilizes mid-infrared ATR spectroscopy to assess glucose-specific absorption without relying on fragile fiber optics.
How has GlucoSense been validated?
Its performance has been tested through collaboration with the University of Applied Sciences and Arts Northwestern Switzerland, confirming its accuracy and reliability.
What are Hamilton's future plans for GlucoSense?
Hamilton plans to release a SIP-compatible version, expanding its applicability across various manufacturing stages, from R&D to large-scale productions.
